Microbleeds in moyamoya disease: Susceptibility-weighted imaging versus t2*-weighted imaging at 3 tesla

Investigative Radiology

Volumn 43, Issue 8, 2008, Pages 574-579

  Mori, Nobuyuki ^a   Miki, Yukio ^a   Kikuta, Ken Ichiro ^a   Fushimi, Yasutaka ^b   Okada, Tsutomu ^c   Urayama, Shin Ichi ^a   Sawamoto, Nobukatsu ^a   Fukuyama, Hidenao ^a   Hashimoto, Nobuo ^a   Togashi, Kaori ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Hikone Municipal Hospital   (Japan)

^c TENRI HOSPITAL   (Japan)

Author keywords

3 T; Cerebral microbleed; Moyamoya disease; Susceptibility weighted imaging

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMAGE INTENSIFIER; MOYAMOYA DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHOOL CHILD; WILCOXON SIGNED RANKS TEST; COMPARATIVE STUDY; FEMALE; IMAGE ENHANCEMENT; MALE; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; CEREBRAL HEMORRHAGE; CHILD; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOYAMOYA DISEASE; PROSPECTIVE STUDIES;

EID: 49849099612     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e31817fb432     Document Type: Article

References (34)

1. Suzuki J, Takaku A. Cerebrovascular "Moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20:288-299.
2. Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('Moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg. 1997;99(suppl 2):S238-S240.
3. Chiu D, Shedden P, Bratina P, et al. Clinical features of Moyamoya disease in the United States. Stroke. 1998;29:1347-1351.
4. Peerless SJ. Risk factors of Moyamoya disease in Canada and the USA. Clin Neurol Neurosurg. 1997;99(suppl 2):S45-S48.
5. Khan N, Schuknecht B, Boltshauser E, et al. Moyamoya disease and Moyamoya syndrome: experience in Europe; choice of revascularisation procedures. Ada Neurochir (Wien). 2003;145:1061-1071; discussion, iSO,etal.
6. Matsushima T, Inoue TK, Suzuki SO, et al. Surgical techniques and the results of a fronto-temporo-parietal combined indirect bypass procedure for children with Moyamoya disease: a comparison with the results of encephalo-duro-arterio-synangiosis alone. Clin Neurol Neurosurg. 1997; 99(suppl 2):S123-S127.
7. Kikuta K, Takagi Y, Nozaki K, et al. Asymptomatic microbleeds in Moyamoya disease: T2*-weighted gradient-echo magnetic resonance imaging study. J Neurosurg. 2005;102:470-475.
8. Ishikawa T, Kuroda S, Nakayama N, et al. Prevalence of asymptomatic microbleeds in patients with Moyamoya disease. Neurol Med Chir (Tokyo). 2005;45:495-500; discussion, 500.
9. Fazekas F, Kleinert R, Roob G, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathyrelated microbleeds. AJNR Am J Neuroradiol. 1999;20:637-642.
10. Schmitz BL, Aschoff AJ, Hoffmann MH, et al. Advantages and pitfalls in 3T MR brain imaging: a pictorial review. AJNR Am J Neuroradiol. 2005;26:2229-2237.
11. Reichenbach JR, Venkatesan R, Schillinger DJ, et al. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology. 1997;204:272-277.
12. Haacke EM, Xu Y, Cheng YC, et al. Susceptibility weighted imaging (SWI). Magn Reson Med. 2004;52:612-618.
13. Sehgal V, Delproposto Z, Haacke EM, et al. Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging. 2005;22:439-450.
14. Wycliffe ND, Choe J, Holshouser B, et al. Reliability in detection of hemorrhage in acute stroke by a new three-dimensional gradient recalled echo susceptibility-weighted imaging technique compared to computed tomography: a retrospective study. J Magn Reson Imaging. 2004;20: 372-377.
15. Tong KA, Ashwal S, Holshouser BA, et al. Hemorrhagic shearing lesions in children and adolescents with posttraumatic diffuse axonal injury: improved detection and initial results. Radiology. 2003;227:332-339.
16. Pinker K, Stavrou I, Szomolanyi P, et al. Improved preoperative evaluation of cerebral cavernomas by high-field, high-resolution susceptibility-weighted magnetic resonance imaging at 3 Tesla: comparison with standard (1.5 T) magnetic resonance imaging and correlation with histopathological findings-preliminary results. Invest Radiol. 2007;42: 346-351.
17. Essig M, Reichenbach JR, Schad LR, et al. High-resolution MR venography of cerebral arteriovenous malformations. Magn Reson Imaging. 1999;17:1417-1425.
18. Haacke EM, Cheng NY, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging. 2005; 23:1-25.
19. Sehgal V, Delproposto Z, Haddar D, et al. Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging. 2006;24:41-51.
20. Haacke EM, DelProposto ZS, Chaturvedi S, et al. Imaging cerebral amyloid angiopathy with susceptibility-weighted imaging. AJNR Am J Neuroradiol. 2007;28:316-317.
21. Reichenbach JR, Haacke EM. High-resolution BOLD venographic imaging: a window into brain function. NMR Biomed. 2001;14:453-467.
22. Wansapura JP, Holland SK, Dunn RS, et al. NMR relaxation times in the human brain at 3.0 tesla. J Magn Reson Imaging. 1999;9:531-538.
23. Reichenbach JR, Barth M, Haacke EM, et al. High-resolution MR venography at 3.0 Tesla. J Comput Assist Tomogr. 2000;24:949-957.
24. Noebauer-Huhmann IM, Pinker K, Barth M, et al. Contrast-enhanced, high-resolution, susceptibility-weighted magnetic resonance imaging of the brain: dose-dependent optimization at 3 Tesla and 1.5 Tesla in healthy volunteers. Invest Radiol. 2006;41:249-255.
25. Tanaka A, Ueno Y, Nakayama Y, et al. Small chronic hemorrhages and ischemic lesions in association with spontaneous intracerebral hematomas. Stroke. 1999;30:1637-1642.
26. Roob G, Schmidt R, Kapeller P, et al. MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology. 1999;52:991-994.
27. de Souza JM, Domingues RC, Cruz LC Jr, et al. Susceptibility-weighted imaging for the evaluation of patients with familial cerebral cavernous malformations: a comparison with T2-weighted fast spin-echo and gradient-echo sequences. AJNR Am J Neuroradiol. 2008;29:154-158.
28. Yoshida Y, Yoshimoto T, Shirane R, et al. Clinical course, surgical management, and long-term outcome of Moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: an extensive follow-up study. Stroke. 1999;30:2272-2276.
29. Kobayashi E, Saeki N, Oishi H, et al. Long-term natural history of hemorrhagic Moyamoya disease in 42 patients. J Neurosurg. 2000;93: 976-980.
30. Fujii K, Ikezaki K, Irikura K, et al. The efficacy of bypass surgery for the patients with hemorrhagic moyamoya disease. Clin Neurol Neurosurg. 1997;99(suppl 2):S194-S195.
31. Kato H, Izumiyama M, Izumiyama K, et al. Silent cerebral microbleeds on T2*-weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis. Stroke. 2002;33:1536-1540.
32. Tsushima Y, Aoki J, Endo K. Brain microhemorrhages detected on T2*-weighted gradient-echo MR images. AJNR Am J Neuroradiol. 2003;24:88-96.
33. Fushimi Y, Miki Y, Kikuta K, et al. Comparison of 3.0- and 1.5-T three-dimensional time-of-flight MR angiography in Moyamoya disease: preliminary experience. Radiology. 2006;239:232-237.
34. Kamata I, Terai Y, Ohmoto T. Attempt to establish an experimental animal model of Moyamoya disease using immuno-embolic materialhistological changes of the arterial wall resulting from immunological reaction in cats. Acta Med Okayama. 2003;57:143-150.